Differential Diagnosis and Treatment of Neonatal Retro-Peritoneal Masses

何炜婧,郑珊,沈淳,董岿然
DOI: https://doi.org/10.3969/j.issn.1671-6353.2008.06.005
2008-01-01
Abstract:Objective Toinvestigatethediagnosisand treatmentstrategyofretroperitonealmassesin neonate. Methods From 2003 to 2008, there were 12 neonates younger than 2 mouth (male 8, female 4) suffering with retroperitoneal masses admitted in our hospital. And their clinical symptoms, imageological findings, therapeutic measures, and prognosis were retrospectively analyzed. Results Adrenal hematomas but diagnosed as cystoid masses by ultrasound and CT was identified in four patients who were treated by antiinfection and haemostasis therapy. The followup showed that the hematomas were gradually assimilated. Three patients were diagnosed as neuroblastoma, which presented cystoids or solid masses in ultrasound and CT. One of them was evaluated as stage IVs and received chemotherapy, complete resection, and then chemotherapy according to the project. Follow- ups showed no recurrence or metastasis. Another one was stage I and received no treatment. Follow- ups showed the mass start to regress after two months. The other one was stage IV and the parents gave up. Five of the twelve patients were teratoma, which presented mixed masses with calcification. Four received complete resection. One died for hemorrhagic shock and the others recovered well. Conclusions Most cases of retroperitoneal masses in neonate can be diagnosed correctly by imaging. Patients of adrenal hematoma do not need operation because the hematoma can be gradually assimilated. Neonatal neuroblastoma can be treated with operation combined with chemotherapy, although some neonatal neuroblastomas have chance of spontaneous regression and need no operation. Most of neonatal teratomas are benign tumors and can be resected and the prognosis is good.
What problem does this paper attempt to address?